Tetrahydropapaveroline
From DrugPedia: A Wikipedia for Drug discovery
| Tetrahydropapaveroline
| |
| Systematic (IUPAC) name | |
| 1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C16H17NO4 |
| Mol. mass | 287.31048 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
A leukomaine (animal alkaloid) formed in brain and liver from dopamine and L-dopa; it may be implicated in psychiatric problems.
The inhibitory effects of tetrahydropapaveroline on serotonin biosynthesis in serotonin-producing murine mastocytoma P815 cells were investigated. Tetrahydropapaveroline decreased serotonin content in a concentration-dependent manner in P815 cells and showed 44.9% reduction of serotonin content at a concentration of 5.0 μM for 24 h.(Kim et al, 2002)
[edit] General Properties
*Molecular Weight
287.31048
*Molecular Formula
C16H17NO4
*IUPAC NAME
1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol
*Canonical Smiles
C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC(=C(C=C3)O)O
*Isomeric Smiles
N/A
*XLogP
1.3
*Topological Polar Surface Area
93
